explore -WSS

explore

author：knowledge 2025-10-01 00:49:54 - browse：281

This image provided by Novo Nordisk in January 2023, shows packaging for the company's Wegovy drug. — Novo Nordisk via AP

PHILADELPHIA — Novo Nordisk’s obesity drug Wegovy notably cut the risk of heart attacks in a landmark cardiovascular trial that affirms the treatment offers health benefits beyond weight loss.

The company in August had announced that in this trial, called Select, Wegovy reduced the overall rate of major heart problems — heart attacks, stroke, or cardiovascular-related death — by 20%. That finding, which was the primary outcome the trial set out to study, was stronger than many were expecting and led Novo’s stock to surge.

But details of the study, including risk reductions for each specific heart complication, were not released until Saturday, when they were presented here — before a standing-room only crowd — as the first major session of the American Heart Association conference.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Time to name cancers by genetics, not organ of origin, expert says

WSS

Jerome Adams on the need for new antivirals for Covid

Biden administration opens offers in Medicare drug price negotiations

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Medical leaders decry Supreme Court decision on affirmative action

Even great ERs can’t make up for American health disparities

Congressmen charge Covid hearing ‘could have been an email’

explore

explore

leisure time

DIEP, the 'gold standard' of breast reconstruction, is under threat

As demand for Covid shots wanes, Moderna seeks its next success

Supreme Court strikes down use of affirmative action

What we need to know about Arena Bioworks

State Dept. review finds Biden bears some blame for Afghanistan failures

Medicare proposal to cover medical devices draws a mixed reaction

Supreme Court strikes down use of affirmative action

Continuity nursing helped my family in our darkest PICU moments

In Memoriam: Notable people who died in 2023

Cybersecurity threat forces Lurie Children's to take systems offline

leisure time

Commercial surrogacy can be ethical, despite pope’s claims

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

The cancer drug shortage isn’t new — and neither are the solutions

Anesthesiologist group: stop taking Ozempic before surgery

Commercial surrogacy can be ethical, despite pope’s claims

Supreme Court strikes down use of affirmative action

knowledge

focus

explore

hotspot